Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Oxford University has today unveiled two access schemes which will enable more academically talented students from under-represented backgrounds to successfully apply to study.

© Panoramic view of Oxford Credit: Sheng Peng

The combined impact of the ambitious programmes represents a major progression for the University, with one Oxford undergraduate in four set to be from the UK’s most under-represented backgrounds by 2023.

The two new programmes – Opportunity Oxford and Foundation Oxford – aim to increase significantly the number of most promising students from groups who are currently under-represented in Oxford. Opportunity Oxford is aimed at students from more disadvantaged socio-economic backgrounds. Foundation Oxford will be open to students who have personally experienced severe disadvantage or educational disruption.

When fully up and running, these major new programmes will offer transformative paths to outstanding education for up to 250 state school students a year, representing 10% of Oxford’s UK undergraduate intake. This represents a significant step change for the University, boosting the proportion of students coming to Oxford from under-represented backgrounds from 15% of the current UK intake to 25%.

Find out more (University of Oxford website)

Similar stories

Long COVID: vaccination could reduce symptoms, new research suggests

While evidence suggests that people who are vaccinated before they get COVID are less likely to develop long COVID than unvaccinated people, the effectiveness of vaccination on existing long COVID has been less clear.

Com-COV vaccine study to research third dose booster options for 12-to-15-year-olds

Researchers running the University of Oxford-led Com-COV programme have launched a further study of COVID-19 vaccination schedules in young people aged 12 to 15 – with a focus on assessing different options for a third dose booster vaccination.

Population-scale study highlights ongoing risk of COVID-19 in some cancer patients despite vaccination

COVID-19 vaccination is effective in most cancer patients, but the level of protection against COVID-19 infection, hospitalisation and death offered by the vaccine is less than in the general population and vaccine effectiveness wanes more quickly.

New reporting guidelines developed to improve AI in healthcare settings

New reporting guidelines, jointly published in Nature Medicine and the BMJ by Oxford researchers, will ensure that early studies on using Artificial Intelligence (AI) to treat real patients will give researchers the information needed to develop AI systems safely and effectively.

Major boost for Oxford’s mission to counter future pandemic threats

The Moh Family Foundation has given a substantial gift to support the work of Oxford University’s Pandemic Sciences Institute, greatly strengthening its ability to identify and counter future pandemic threats and ensure equitable access to treatments and vaccines around the world.